Congenital Heart Disease Research
University of Chicago Medicine heart specialists are researching new and better methods to evaluate and treat congenital heart disease. Our pediatric cardiologists are studying experimental devices to close holes in the heart caused by some common forms of congenital heart disease. University of Chicago pediatric cardiologists spearheaded a study of the Amplatzer Septal Occluder, an innovative device that was approved by the FDA for use to close atrial septal defects.
Scientists at the University of Chicago are also actively researching the basic science of cardiovascular disease, including the genetics of heart disease and gene therapy methods.